I've been a Novo Nordisk bull for quite some time now, and I wouldn't be as spooked by the situation. Here's why. Novo Nordisk got a two-year-plus head start in the white-hot obesity drugs market, ...

Take a fascinating look back at the science and technology advances that shaped medicine’s past and will define its future.

Older adults taking GLP-1 receptor agonists, primarily semaglutide (Rybelsus, Ozempic, Wegovy), had a small uptick in their ...

THURSDAY, June 5, 2025 (HealthDay News) — More American teenagers now use the weight-loss drug Wegovy, as doctors and ...

In this randomized controlled trial, oral semaglutide significantly reduced the risk of adverse cardiovascular events in ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.